David Gold

David Gold is a Senior Associate in the New York office and a member of Orrick’s Corporate Business Unit and M&A and Private Equity Group.

• Engagements

  Technology

  Represented Shopify Inc. in several transactions, including the following:

  • Acquisition of the outstanding equity of 6 River Systems, Inc., a leading provider of collaborative warehouse fulfillment solutions Acquisition of the outstanding equity of Handshake Corp., a New York-based B2B e-commerce platform
  • Acquisition of the outstanding equity of Tictail, a Swedish e-commerce marketplace provider

  Represented Pitney Bowes Inc. in its sale of the Tacit Knowledge digital commerce solutions business to Grid Dynamics

  Represented Sailthru Inc., a New York based marketing automation firm, in its equity sale to Campaign Monitor

  Represented Avaya Inc. in connection with its acquisition of the outstanding equity of CTIntegrations, LLC

  Energy and Infrastructure

  Represented affiliates of Macquarie Group Limited in several transactions, including the following:

  • The acquisition of the outstanding equity of Cyrq Energy, Inc., a U.S. geothermal power company based in Utah
  • The acquisition of the outstanding equity of Hudson Ranch I Holdings LLC, a geothermal power company based in California
  • The joint sale by Macquarie and Skanska of the outstanding equity of Elizabeth River Crossings HoldCo LLC, which operates and maintains the Elizabeth River Tunnels Project, to Abertis and Manulife Investment Management
  • The sale of the outstanding equity of Fraser Surrey Docks, a Canadian marine terminal, to DP World
  • The sale of the outstanding equity of Halterm, a Canadian marine terminal, and Penn Terminals, a Pennsylvania marine terminal, to PSA International

  Represented Enlight Renewable Energy Ltd in its acquisition of a controlling interest in Clenera, LLC and several renewable energy projects in the U.S.

  Life Sciences

  Represented ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) in several transactions, including the following:

  • The acquisition of three generic products and one branded product from Sandoz Inc.
  • The acquisition of a U.S. portfolio of 23 generic products from Amerigen Pharmaceuticals, Ltd.
  • The acquisition of the generic product Fluconazole from Harris Pharmaceutical, Inc.
  • The acquisition of the outstanding equity of WellSpring Pharma Services, Inc. a Canadian contract development and manufacturing organization

  Represented Guide Therapeutics, Inc., a biotechnology company developing precision genetic medicines, in its equity sale to Beam Therapeutics Inc.

  Represented Euclid Systems Corporation, a global leader in myopia treatment, in its equity sale to an affiliate of Hillhouse Capital Group

  Represented Sizewise, a global medical equipment manufacturer, in its sale to Agiliti (NYSE: AGTI), a service provider to the U.S. healthcare industry ($230 million)
  

  While at his prior firm, represented Merck & Co. in its acquisitions of Cubist Pharmaceuticals and Idenix Pharmaceuticals

  Transportation

  Represented Fisker Inc. (NYSE: FSR), an electric vehicle manufacturer, in its sale to Spartan Energy Acquisition Corp., a SPAC sponsored by an affiliate of Apollo Global Management, Inc.

  Represented Battle Motors Inc. in its acquisition of the outstanding equity of Crane Carrier Company, LLC, a commercial vehicle OEM

  Represented SPII Holdings Inc., a company controlled by DryShips Inc.’s chairman and CEO George Economou, in a “go-private” transaction